Discover more insights into Eslicarbazepine Acetate 에스리카르바제핀 아세테이트

Keywords frequently search together with Eslicarbazepine Acetate 에스리카르바제핀 아세테이트

Narrow sentence examples with built-in keyword filters

Comparative economic outcomes in patients with focal seizures initiating Eslicarbazepine Acetate versus Brivaracetam as their first adjunctive ASD.

Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study

Initial or early monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies.

Multiple drugs

Initiating antiepilepsy treatment: An update of expert consensus in Spain

Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis

Simple and efficient method for the quantification of antiepileptic drugs in human plasma by using magnetic graphene oxide-β-cyclodextrin composite as a sorbent

Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures

[Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].

Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy

Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of AADAC Genetic Polymorphisms on Hydrolase Activity

Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience

Clinical outcomes of eslicarbazepine acetate monotherapy for focal‐onset seizures: A multicenter audit

A highly sensitive HPTLC method for estimation of oxcarbazepine in two binary mixtures with two metabolically related antiepileptic drugs: Application to pharmaceutical and biological samples

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

[New anti-epileptic drugs in Paediatrics].

Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study

Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta‐analysis

Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures

Carnitine Deficiency in a Patient with Shapiro Syndrome

MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro‐Esli

Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical practice study

Serum sodium levels and related treatment‐emergent adverse events during eslicarbazepine acetate use in adults with epilepsy

Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study

Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate

Anti-epileptic medications

[New anti-epileptic drugs in Paediatrics].

Health-related quality of life in patients treated with eslicarbazepine acetate monotherapy: Pooled analysis from two registered clinical trials

Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy

Learn more from Eslicarbazepine Acetate 에스리카르바제핀 아세테이트

Keywords related to Eslicarbazepine

Eslicarbazepine Acetate 에스리카르바제핀 아세테이트

Eslicarbazepine Acetate 에스리카르바제핀 아세테이트
Encyclopedia 백과사전